- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Atezolizumab
Total 759 results
-
Hoffmann-La RocheCompletedColorectal CancerCanada, United States, Italy, Korea, Republic of, United Kingdom, Belgium, Russian Federation, Hong Kong, Spain, Australia, Poland
-
University of ArizonaRecruitingPancreatic Cancer | Metastatic Pancreatic CancerUnited States
-
Hoffmann-La RocheRecruitingPD-L1-selected Solid TumorsSpain, Korea, Republic of, China, Taiwan, Turkey, Greece, United States, Croatia, Serbia, Canada, Mexico, Cyprus, Georgia
-
University Medical Center GroningenRecruitingMelanoma | Head and Neck Neoplasms | MSI-H CancerNetherlands
-
Keythera Pharmaceuticals (Australia) Pty LtdRecruitingGastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the EsophagusAustralia
-
University Hospital Southampton NHS Foundation...Roche Pharma AG; Cancer Research UKRecruitingSquamous Cell Carcinoma | Urinary Tract CancerUnited Kingdom
-
National Cancer Center, KoreaRoche Korea co.,Ltd.RecruitingSequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC (Atezolizumab)Small Cell Lung Cancer RecurrentKorea, Republic of
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungItaly, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.; Stand Up To CancerTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Estrogen Receptor-positiveUnited States
-
Queen Mary University of LondonHoffmann-La RocheUnknownBladder CancerUnited Kingdom, France, Spain, Netherlands
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Belgium, Hong Kong, Italy, Slovenia, Australia, Canada, Bulgaria, Germany, France, Georgia, Singapore, Spain, Bosnia and Herzegovina, Switzerland, Turkey, Japan, United Kingdom, Netherlands
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, United Kingdom, Belgium, Netherlands
-
Hoffmann-La RocheTerminated
-
University Medical Center GroningenRecruiting
-
Base Therapeutics (Shanghai) Co., Ltd.Shanghai 10th People's HospitalEnrolling by invitation
-
Nykode Therapeutics ASARoche Pharma AG; GOG FoundationRecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related Cervical CarcinomaUnited States
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
Institute of Cancer Research, United KingdomHoffmann-La RocheRecruitingSolid Tumor | Glioblastoma Multiforme | Prostate Cancer MetastaticUnited Kingdom
-
Beijing Syngentech Co., Ltd.Not yet recruitingHepatocellular Carcinoma
-
Bavarian NordicCompletedBladder CancerUnited States
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Canada, France, Italy, Netherlands
-
University of Michigan Rogel Cancer CenterTerminated
-
Niharika MettuRoche-GenentechWithdrawnMetastatic Colorectal CancerUnited States
-
CHA UniversityRecruitingHepatocellular CarcinomaKorea, Republic of
-
Hoffmann-La RocheCompleted
-
Tracon Pharmaceuticals Inc.Active, not recruitingSolid Tumor | Metastatic CancerUnited States
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
Genentech, Inc.CompletedHematologic Malignancies | TumorsSpain, France, United States, United Kingdom
-
McGill University Health Centre/Research Institute...Unknown
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Base Therapeutics (Shanghai) Co., Ltd.The General Hospital of Eastern Theater CommandRecruiting
-
Centre Antoine LacassagneRoche Pharma AG; Centre Hospitalier Universitaire de CaenRecruitingSarcoma | RadiosurgeryFrance
-
Regeneron PharmaceuticalsNovella ClinicalCompletedNon Small Cell Lung CancerUnited States
-
University of UtahGenentech, Inc.; Bavarian NordicWithdrawnProstate AdenocarcinomaUnited States
-
Fox Chase Cancer CenterStand Up To Cancer; Van Andel Research InstituteActive, not recruitingUrothelial CarcinomaUnited States
-
Oslo University HospitalTerminatedNon-small Cell Lung CancerNorway
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Glenmark Specialty S.A.RecruitingLymphoma | Advanced Solid TumorUnited States, India
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of
-
James BrugarolasRecruitingRenal Cell CarcinomaUnited States
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
CHA UniversityHoffmann-La RocheCompletedAdvanced Hepatocellular CarcinomaKorea, Republic of
-
I-Mab Biopharma US LimitedNo longer availableCancerUnited States
-
The Netherlands Cancer InstituteRoche Pharma AGTerminatedBreast CancerNetherlands
-
The Lymphoma Academic Research OrganisationRoche Pharma AGTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin LymphomaFrance
-
Hoffmann-La RocheWithdrawn
-
Darell BignerGenentech, Inc.; Istari Oncology, Inc.Withdrawn